ストックスクリーナーアプリを入手
2.13
0.47%
0.010
前日終値:
$2.12
開ける：
$2.1
24時間の取引高:
46,781
Relative Volume:
0.67
時価総額：
$86.59M
収益：
$2.70M
当期純損益:
$5.53M
株価収益率:
19.36
EPS:
0.11
ネットキャッシュフロー:
$-10.55M
1週間 パフォーマンス:
+2.40%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
-11.25%
1年 パフォーマンス:
-4.91%
1日の値動き範囲:
$2.10
$2.14
1週間の範囲:
$2.06
$2.143
52週間の値動き範囲:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
名前
Oramed Pharmaceuticals Inc
セクター
電話
646-844-1164
住所
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
ORMP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.12 | 85.77M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.94 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
570.16 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
439.15 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
648.97 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.49 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-01-12 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-20 | 開始されました | Canaccord Genuity | Buy |
| 2021-02-09 | 開始されました | National Securities | Buy |
| 2020-12-03 | 開始されました | Alliance Global Partners | Buy |
| 2020-03-11 | 開始されました | Aegis Capital | Buy |
| 2019-09-11 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-12-11 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | 繰り返されました | FBR Capital | Outperform |
| 2015-12-01 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-11-19 | 開始されました | FBR Capital | Outperform |
| 2015-04-13 | 再開されました | MLV & Co | Buy |
| 2014-01-30 | 繰り返されました | Aegis Capital | Buy |
| 2014-01-08 | 繰り返されました | Aegis Capital | Buy |
| 2014-01-08 | 開始されました | MLV & Co | Buy |
| 2013-12-03 | 開始されました | Aegis Capital | Buy |
すべてを表示
Oramed Pharmaceuticals Inc (ORMP) 最新ニュース
Published on: 2025-08-14 06:23:37 - Newser
Detecting price anomalies in Oramed Pharmaceuticals Inc. with AITreasury Yields & Weekly Chart Analysis and Trade Guides - Newser
Oramed Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowQuarterly Profit Report & Fast Entry Momentum Trade Alerts - Newser
Can machine learning forecast Oramed Pharmaceuticals Inc. recoveryEarnings Summary Report & Real-Time Buy Signal Alerts - Newser
Scilex Holding Company Announces S-4 Effectiveness, Denali-Semnur Merger Proposal, and Oramed Pharmaceuticals Enters Option Agreement with Scilex - AInvest
Is Oramed Pharmaceuticals Inc. forming a reversal patternJuly 2025 Levels & Verified Swing Trading Watchlist - Newser
Can volume confirm reversal in Oramed Pharmaceuticals Inc.2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
How to use Fibonacci retracement on Oramed Pharmaceuticals Inc.2025 Market Outlook & Smart Swing Trading Alerts - Newser
How high can Oramed Pharmaceuticals Inc. stock goFree Watchlist for Low Risk High Return - Newser
How Oramed Pharmaceuticals Inc. stock performs during market volatilityFree Daily Chart Pattern Stock Forecast - Newser
Is now a turning point for Oramed Pharmaceuticals Inc.AI Volatility Forecast and Risk Monitor - Newser
Alpha Tau Secures FDA Approval for Breakthrough Brain Cancer Treatment Trial, Raises $36.9M - Stock Titan
What to expect from Oramed Pharmaceuticals Inc. in the next 30 daysFree Stock Market Entry Timing Signals - Newser
Risk vs reward if holding onto Oramed Pharmaceuticals Inc.Daily Technical Chart Pattern Analysis Report - Newser
Can you recover from losses in Oramed Pharmaceuticals Inc.Free Short Term High Yield Stock Tips - Newser
Published on: 2025-08-10 20:12:47 - Newser
Can a trend reversal in Oramed Pharmaceuticals Inc. lead to recoveryFree Risk Adjusted Technical Entry Plan - Newser
Intraday pattern recognizer results for Oramed Pharmaceuticals Inc.Daily Exit and Entry Price Prediction - Newser
Diabetic Ketacidosis Treatment Market Set to Witness - openPR.com
What makes Oramed Pharmaceuticals Inc. stock price move sharplyMulti-Year Investment Performance Summary Report - Newser
What candlestick patterns are forming on Oramed Pharmaceuticals Inc.Daily Market Entry Strategy with Tools - Newser
Published on: 2025-08-05 21:05:42 - Newser
Recovery Signals Appearing in Oramed Pharmaceuticals Inc. ChartsReal Trader Watchlist of Hot Stocks Released - beatles.ru
How does Oramed Pharmaceuticals Inc. generate profit in a changing economyIdentify winners with top-tier analysis - Jammu Links News
What are analysts’ price targets for Oramed Pharmaceuticals Inc. in the next 12 monthsBuild wealth steadily with expert advice - Jammu Links News
How does Oramed Pharmaceuticals Inc. compare to its industry peersTriple-digit wealth increases - Jammu Links News
Should I hold or sell Oramed Pharmaceuticals Inc. stock in 2025Maximize gains with expert analysis - Jammu Links News
Is it the right time to buy Oramed Pharmaceuticals Inc. stockFree Market Dynamics Reports - Jammu Links News
Oramed Pharmaceuticals Inc. Stock Analysis and ForecastDiscover high-impact stocks for your portfolio - Jammu Links News
What is the dividend policy of Oramed Pharmaceuticals Inc. stockTap into rapid wealth building techniques - Jammu Links News
What are the latest earnings results for Oramed Pharmaceuticals Inc.Value Investing Review From AI Tools - Jammu Links News
Is Oramed Pharmaceuticals Inc. stock overvalued or undervaluedAI Powered Ideas With High Returns - Jammu Links News
Diabetes Pipeline 2025: Therapies Under Investigation, - openPR.com
Key External Factors That Drive Oramed Pharmaceuticals Inc. Stock Price MovementsConsistent Return Setup with Exit Strategy - Newser
How high can Oramed Pharmaceuticals Inc. stock price go in 2025Trend Following Ideas with Volume Confirmation - Newser
What are the technical indicators suggesting about Oramed Pharmaceuticals Inc.Advanced Screener Entry Points For Consistent Profits - Jammu Links News
Published on: 2025-07-30 11:09:17 - metal.it
Oramed Pharmaceuticals Inc (ORMP) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
1.49%
大文字化:
|
ボリューム (24 時間):